Three-vessel coronary disease in diabetics: personalized versus evidence-based revascularization strategy
Giuseppe Tarantini and Davide Lanzellotti discuss the challenges and best practices in treating heart disease on patients with diabetes. This review, from Future Cardiology, is free to access exclusively for Evidence Base members.
Please sign in or register for FREE
Sign in to The Evidence Base
Did you know?
Your The Evidence Base™ account also gives you access to communities on regenerative medicine, real-world evidence and drug discovery. Find out more>>